Thus, HJURP/PRDX1 may be used as biomarkers for predicting the response of PCa cells to ferroptosis inducers and are promising therapeutic targets for overcoming PCa ferroptotic resistance. The gene discussed is PRDX1; the disease is posterior cortical atrophy.